Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.2K Sell
752
-28
-4% -$1.31K ﹤0.01% 1380
2025
Q4
$37.8K Buy
780
+77
+11% +$3.82K ﹤0.01% 1342
2025
Q3
$33.2K Sell
703
-337
-32% -$16.3K ﹤0.01% 1288
2025
Q2
$50.2K Sell
1,040
-84
-7% -$4.29K ﹤0.01% 1116
2025
Q1
$62.3K Buy
1,124
+264
+31% +$14.3K ﹤0.01% 963
2024
Q4
$41.5K Sell
860
-213
-20% -$10.8K ﹤0.01% 986
2024
Q3
$61.8K Buy
1,073
+302
+39% +$16.3K ﹤0.01% 813
2024
Q2
$37.4K Sell
771
-192
-20% -$9.26K ﹤0.01% 892
2024
Q1
$46.8K Sell
963
-88
-8% -$4.3K ﹤0.01% 849
2023
Q4
$52.3K Sell
1,051
-825
-44% -$40.3K ﹤0.01% 819
2023
Q3
$101K Buy
1,876
+524
+39% +$27.9K ﹤0.01% 693
2023
Q2
$72.9K Sell
1,352
-755
-36% -$40.6K ﹤0.01% 759
2023
Q1
$115K Buy
2,107
+802
+61% +$39K ﹤0.01% 668
2022
Q4
$63K Sell
1,305
-725
-36% -$31.8K ﹤0.01% 793
2022
Q3
$77K Sell
2,030
-12,509
-86% -$557K ﹤0.01% 773
2022
Q2
$727K Sell
14,539
-693
-5% -$36.8K 0.01% 411
2022
Q1
$782K Hold
15,232
0.01% 419
2021
Q4
$763K Buy
+15,232
New +$753K 0.01% 422

Other funds holding SNY

UMB Bank's SNY Position: Q1 2026 in Review

UMB Bank reduced its Sanofi (SNY) stake by 3.6% in Q1 2026, selling an estimated $1.31K and leaving 752 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

UMB Bank first reported a position in SNY in Q4 2021 and has held it in 18 quarters since. The position peaked at $782K in Q1 2022. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • UMB Bank held 752 shares of Sanofi worth $36.2K as of Q1 2026.
  • UMB Bank sold 28 Sanofi shares in Q1 2026, an estimated $1.31K.
  • Sanofi made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1380 holding.
  • UMB Bank first reported a position in Sanofi in Q4 2021 and has held it in 18 quarters since.
  • UMB Bank's Sanofi position peaked at $782K in Q1 2022.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.